NCT06350955View on ClinicalTrials.gov

IV Iron-induced Hypophosphatemia After RYGB

PHASE4RecruitingINTERVENTIONAL

Enrollment

94

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

HypophosphatemiaRoux-en-Y Gastric Bypass

Interventions

DRUG

Iron isomaltoside

single dose of 500 mg iron isomaltoside

DRUG

Iron Carboxymaltose

single dose of 500 mg ferric carboxymaltose

Trial Locations (1)

1003

RECRUITING

CHUV, Lausanne

All Listed Sponsors

lead

Lucie Favre

OTHER